Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kozarich

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Current Opinion in Chemical Biology|October 1, 1998
Looking to the horizonKozarich, Rich
Current Opinion in Chemical Biology|August 1, 1997
Next generation therapeutics toward a new era in drug discoveryKozarich, Rich
BMC Biology|July 6, 2010
S28 peptidases: lessons from a seemingly 'dysfunctional' family of twoJohn W Kozarich
Assay and Drug Development Technologies|June 19, 2013
Interview with John W. Kozarich, PhD. Interview by Vicki GlaserJohn W Kozarich
Annual Review of Biochemistry|June 4, 2009
The biochemistry of disease: desperately seeking syzygyJohn W Kozarich
Current Opinion in Chemical Biology|January 28, 2003
Activity-based proteomics: enzyme chemistry reduxJohn W Kozarich
Biofactors (Oxford, England)|July 1, 1988
S-adenosylmethionine-dependent enzyme activationJ W Kozarich
Biochemistry|November 5, 2021
Welcome to <i>Biochemistry</i> Volume 1: No Hyphen RequiredJohn W Kozarich
Chemistry & Biology|September 22, 2007
New LSD therapies unfoldingJohn W Kozarich
Current Opinion in Chemical Biology|August 28, 2003
Prolyl peptidases: a serine protease subfamily with high potential for drug discoveryJonathan S Rosenblum, John W Kozarich
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Current Opinion in Chemical Biology|October 1, 1998
Looking to the horizonKozarich, Rich
Current Opinion in Chemical Biology|August 1, 1997
Next generation therapeutics toward a new era in drug discoveryKozarich, Rich
BMC Biology|July 6, 2010
S28 peptidases: lessons from a seemingly 'dysfunctional' family of twoJohn W Kozarich
Assay and Drug Development Technologies|June 19, 2013
Interview with John W. Kozarich, PhD. Interview by Vicki GlaserJohn W Kozarich
Annual Review of Biochemistry|June 4, 2009
The biochemistry of disease: desperately seeking syzygyJohn W Kozarich
Current Opinion in Chemical Biology|January 28, 2003
Activity-based proteomics: enzyme chemistry reduxJohn W Kozarich
Biofactors (Oxford, England)|July 1, 1988
S-adenosylmethionine-dependent enzyme activationJ W Kozarich
Biochemistry|November 5, 2021
Welcome to <i>Biochemistry</i> Volume 1: No Hyphen RequiredJohn W Kozarich
Chemistry & Biology|September 22, 2007
New LSD therapies unfoldingJohn W Kozarich
Current Opinion in Chemical Biology|August 28, 2003
Prolyl peptidases: a serine protease subfamily with high potential for drug discoveryJonathan S Rosenblum, John W Kozarich
Pageof 12